Wednesday, October 29, 2025
Grünhorn redefines cannabis therapy – Launch of an integrated platform for medical care, knowledge exchange and patient community
Grünhorn is entering a new era of cannabis therapy. The company is transforming from a traditional pharmacy into a comprehensive platform for medical cannabis therapy, offering patients a fully integrated 360-degree experience.
At the heart of this transformation lies an offering that seamlessly combines medical care, digital therapy support, and community connection. The new brand design underscores this shift: Grünhorn becomes more emotional, personal, and focused on patient needs.
“We took a close look at what our patients truly need,” explains Tobias Bosse, Chief Marketing Officer at Grünhorn. “Patients want more than just medication – they want to be understood and supported. That’s exactly why we reimagined Grünhorn.”
Three pillars of the new platform
- Medical care and consultation
The pharmaceutical team guides patients throughout their entire therapy journey, providing expert advice on safe and effective use of prescribed medical cannabis. - Grünhorn Academy for professionals
Doctors and pharmacists gain access to the latest research, treatment guidelines, and practical training through a central knowledge platform dedicated to cannabis therapy. - Community and scientific evaluation
The platform connects patients with one another, fostering structured information exchange. All data is processed in compliance with GDPR and anonymized, making therapy outcomes scientifically measurable and improving treatment quality.
Emotional brand leadership and new identity
The new brand identity was developed in collaboration with Hamburg-based creative agency KNSK. The goal was to enhance Grünhorn’s emotional relevance while clearly communicating its platform strategy. The result is a contemporary brand appearance that unites trust, empathy, and pharmaceutical quality.
“Our new design reflects who we are today: a trusted partner for patients who have found effective therapy with medical cannabis,” says Stefan Fritsch, CEO of Grünhorn.
As Germany’s largest network for medical cannabis, Grünhorn already supports several hundred thousand patients to the highest quality and safety standards. With its new platform model, the company aims to digitally connect and elevate medical cannabis care across Germany, setting a new benchmark for the future of therapy.
